Revolution Medicines, Inc. (RVMD)
203.77
+0.42
(+0.21%)
USD |
NASDAQ |
Sep 11, 16:00
203.85
+0.08
(+0.04%)
After-Hours: 20:00
Revolution Medicines Market Cap : 43.66B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 43.66B |
| September 10, 2026 | 43.57B |
| September 09, 2026 | 44.49B |
| September 08, 2026 | 44.42B |
| September 04, 2026 | 45.00B |
| September 03, 2026 | 45.18B |
| September 02, 2026 | 44.83B |
| September 01, 2026 | 44.96B |
| August 31, 2026 | 44.04B |
| August 28, 2026 | 44.54B |
| August 27, 2026 | 47.38B |
| August 26, 2026 | 46.16B |
| August 25, 2026 | 45.29B |
| August 24, 2026 | 45.33B |
| August 21, 2026 | 44.88B |
| August 20, 2026 | 45.36B |
| August 19, 2026 | 45.99B |
| August 18, 2026 | 46.28B |
| August 17, 2026 | 45.42B |
| August 14, 2026 | 43.64B |
| August 13, 2026 | 43.28B |
| August 12, 2026 | 43.98B |
| August 11, 2026 | 44.04B |
| August 10, 2026 | 44.34B |
| August 07, 2026 | 43.95B |
| Date | Value |
|---|---|
| August 06, 2026 | 42.38B |
| August 05, 2026 | 42.27B |
| August 04, 2026 | 41.45B |
| August 03, 2026 | 39.09B |
| July 31, 2026 | 37.54B |
| July 30, 2026 | 38.47B |
| July 29, 2026 | 36.22B |
| July 28, 2026 | 36.80B |
| July 27, 2026 | 37.65B |
| July 24, 2026 | 37.88B |
| July 23, 2026 | 37.78B |
| July 22, 2026 | 36.64B |
| July 21, 2026 | 36.69B |
| July 20, 2026 | 36.11B |
| July 17, 2026 | 37.27B |
| July 16, 2026 | 35.87B |
| July 15, 2026 | 36.92B |
| July 14, 2026 | 37.03B |
| July 13, 2026 | 36.82B |
| July 10, 2026 | 37.41B |
| July 09, 2026 | 38.26B |
| July 08, 2026 | 37.99B |
| July 07, 2026 | 38.13B |
| July 06, 2026 | 38.03B |
| July 02, 2026 | 37.88B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Erasca, Inc. | 4.963B |
| Moderna, Inc. | 57.44B |
| Tango Therapeutics, Inc. | 4.004B |
| Arrowhead Pharmaceuticals, Inc. | 11.69B |
| Intellia Therapeutics, Inc. | 1.644B |
Market Cap Related Metrics
| PEG Ratio | -0.2416 |
| Price to Book Value | 16.75 |
| Price | 203.77 |
| Earnings Yield | -4.33% |
| PEGY Ratio | -0.2416 |